SINOPHARM (01099) Proposes Appointment of Jin Bin and Li Ying as Non-Executive Directors

Stock News11-28

SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, member of the Legal Compliance and Environmental, Social, and Governance (ESG) Committee, and authorized representative of the company, effective from the date his successor is appointed at the shareholders' meeting. Ms. Feng Rongli has also resigned as Non-Executive Director and member of the Remuneration and Nomination Committees, effective upon the appointment of her successor at the shareholders' meeting.

On the same day, the Board resolved to propose the appointment of Mr. Jin Bin and Ms. Li Ying as Non-Executive Directors. The Board further announced the election of Mr. Jin as Chairman and authorized representative, subject to shareholder approval of his appointment as Non-Executive Director at the shareholders' meeting. Additionally, Mr. Jin was elected as Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, and member of the Legal Compliance and ESG Committee, pending shareholder approval of his Non-Executive Director appointment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172022187?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-28 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172022187","market":"sh","top_or_hot":-1,"title":"SINOPHARM (01099) Proposes Appointment of Jin Bin and Li Ying as Non-Executive Directors","media":"Stock News","content":"<p>SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, member of the Legal Compliance and Environmental, Social, and Governance (ESG) Committee, and authorized representative of the company, effective from the date his successor is appointed at the shareholders' meeting. Ms. Feng Rongli has also resigned as Non-Executive Director and member of the Remuneration and Nomination Committees, effective upon the appointment of her successor at the shareholders' meeting.</p>\n<p>On the same day, the Board resolved to propose the appointment of Mr. Jin Bin and Ms. Li Ying as Non-Executive Directors. The Board further announced the election of Mr. Jin as Chairman and authorized representative, subject to shareholder approval of his appointment as Non-Executive Director at the shareholders' meeting. Additionally, Mr. Jin was elected as Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, and member of the Legal Compliance and ESG Committee, pending shareholder approval of his Non-Executive Director appointment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SINOPHARM (01099) Proposes Appointment of Jin Bin and Li Ying as Non-Executive Directors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSINOPHARM (01099) Proposes Appointment of Jin Bin and Li Ying as Non-Executive Directors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-28 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, member of the Legal Compliance and Environmental, Social, and Governance (ESG) Committee, and authorized representative of the company, effective from the date his successor is appointed at the shareholders' meeting. Ms. Feng Rongli has also resigned as Non-Executive Director and member of the Remuneration and Nomination Committees, effective upon the appointment of her successor at the shareholders' meeting.</p>\n<p>On the same day, the Board resolved to propose the appointment of Mr. Jin Bin and Ms. Li Ying as Non-Executive Directors. The Board further announced the election of Mr. Jin as Chairman and authorized representative, subject to shareholder approval of his appointment as Non-Executive Director at the shareholders' meeting. Additionally, Mr. Jin was elected as Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, and member of the Legal Compliance and ESG Committee, pending shareholder approval of his Non-Executive Director appointment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1115378108.SGD","symbol_name":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","start_time":0,"source_url":"","article_id":"1172022187","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172022187","pubTimestamp":1764341658,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","01099":"国药控股","BK1515":"抗疫概念","BK1500":"做空集合股","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","BK1197":"保健护理产品经销商"},"translate_title":"国药控股(01099)建议委任金斌及李莹为非执行董事","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"SINOPHARM (01099) announced that due to work arrangements, Mr. Zhao Bingxiang has resigned from his positions as Non-Executive Director, Chairman of the Board, Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, member of the Legal Compliance and Environmental, Social, and Governance (ESG) Committee, and authorized representative of the company, effective from the date his successor is appointed at the shareholders' meeting. Ms. Feng Rongli has also resigned as Non-Executive Director and member of the Remuneration and Nomination Committees, effective upon the appointment of her successor at the shareholders' meeting.\nOn the same day, the Board resolved to propose the appointment of Mr. Jin Bin and Ms. Li Ying as Non-Executive Directors. The Board further announced the election of Mr. Jin as Chairman and authorized representative, subject to shareholder approval of his appointment as Non-Executive Director at the shareholders' meeting. Additionally, Mr. Jin was elected as Chairman of the Nomination Committee, Chairman of the Strategy and Investment Committee, and member of the Legal Compliance and ESG Committee, pending shareholder approval of his Non-Executive Director appointment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172022187","isCrawlerRequest":true}